Geode Capital Management, LLC Bio Atla, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 419,998 shares of BCAB stock, worth $138,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

419,998

Previous 405,215 3.65%

Holding current value

$138,599

Previous $713,000 65.36%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.59 - $2.37 $8,721 - $35,035	14,783 Added 3.65%	419,998 $247,000
Q3 2024 Nov 12, 2024	BUY	$1.17 - $2.05 $760 - $1,332	650 Added 0.16%	405,215 $713,000
Q2 2024 Aug 09, 2024	SELL	$1.37 - $3.92 $710,171 - $2.03 Million	-518,373 Reduced 56.17%	404,565 $554,000
Q1 2024 May 13, 2024	BUY	$1.88 - $3.46 $35,453 - $65,248	18,858 Added 2.09%	922,938 $3.17 Million
Q4 2023 Feb 13, 2024	BUY	$1.27 - $3.18 $65,991 - $165,239	51,962 Added 6.1%	904,080 $2.22 Million
Q3 2023 Nov 13, 2023	BUY	$1.7 - $3.07 $35,771 - $64,598	21,042 Added 2.53%	852,118 $1.45 Million
Q2 2023 Aug 11, 2023	BUY	$2.83 - $3.87 $1.29 Million - $1.76 Million	455,642 Added 121.36%	831,076 $2.49 Million
Q1 2023 May 15, 2023	BUY	$2.3 - $8.25 $53,215 - $190,880	23,137 Added 6.57%	375,434 $1.01 Million
Q4 2022 Feb 13, 2023	BUY	$6.29 - $11.01 $510,358 - $893,329	81,138 Added 29.92%	352,297 $2.91 Million
Q3 2022 Nov 14, 2022	BUY	$2.94 - $11.87 $265,414 - $1.07 Million	90,277 Added 49.91%	271,159 $2.09 Million
Q2 2022 Aug 12, 2022	SELL	$2.13 - $5.38 $64,340 - $162,513	-30,207 Reduced 14.31%	180,882 $515,000
Q1 2022 May 13, 2022	SELL	$4.38 - $18.78 $342,975 - $1.47 Million	-78,305 Reduced 27.06%	211,089 $1.06 Million
Q4 2021 Feb 11, 2022	BUY	$19.0 - $30.95 $1.91 Million - $3.12 Million	100,767 Added 53.42%	289,394 $5.68 Million
Q3 2021 Nov 12, 2021	SELL	$29.44 - $43.74 $433,356 - $643,852	-14,720 Reduced 7.24%	188,627 $5.55 Million
Q2 2021 Aug 13, 2021	BUY	$38.07 - $56.17 $319,597 - $471,547	8,395 Added 4.31%	203,347 $8.62 Million
Q1 2021 May 12, 2021	BUY	$32.41 - $70.91 $5.75 Million - $12.6 Million	177,513 Added 1017.91%	194,952 $9.91 Million
Q4 2020 Feb 12, 2021	BUY	$31.02 - $35.16 $540,957 - $613,155	17,439 New	17,439 $593,000

Others Institutions Holding BCAB

# of Institutions

Shares Held

23.4M

Call Options Held

30.8K

Put Options Held

57K

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $12M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Bio Atla, Inc. Transaction History